Intelligence Β· Clinical Pipeline

NEUROCRINE BIOSCIENCES Pipeline

All ClinicalTrials.gov programs at NEUROCRINE BIOSCIENCES β€” phase, modality, and trial IDs.

Programs
25

Quick answer

NEUROCRINE BIOSCIENCES has 25 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Chronocort

    NEUROCRINE BIOSCIENCES INC

    Primary Adrenal Insufficiency

    phase 2 small molecule completed

    1 trial
  2. Crinecerfont

    NEUROCRINE BIOSCIENCES INC

    CAH - Congenital Adrenal Hyperplasia

    phase 2 small molecule completed

    1 trial
  3. Hydrocortisone Modified Release Capsules

    NEUROCRINE BIOSCIENCES INC

    Endocrine Disease

    phase 2 small molecule completed

    1 trial
  4. Luvadaxistat

    NEUROCRINE BIOSCIENCES INC

    Schizophrenia

    phase 2 small molecule completed

    2 trials
  5. NBI-1065890

    NEUROCRINE BIOSCIENCES INC

    Tardive Dyskinesia

    phase 2 small molecule active

    1 trial
  6. NBI-1070770

    NEUROCRINE BIOSCIENCES INC

    Major Depressive Disorder

    phase 2 small molecule completed

    1 trial
  7. NBI-1117568

    NEUROCRINE BIOSCIENCES INC

    Bipolar I Disorder

    phase 2 small molecule active

    1 trial
  8. NBI-1117570

    NEUROCRINE BIOSCIENCES INC

    Schizophrenia

    phase 2 small molecule active

    1 trial
  9. NBI-1117570, NBI-1117570, Placebo for nbi-1117570

    NEUROCRINE BIOSCIENCES INC

    Schizophrenia

    phase 2 small molecule active

    1 trial
  10. NBI-5788

    NEUROCRINE BIOSCIENCES INC

    Multiple Sclerosis

    phase 2 small molecule completed

    1 trial
  11. NBI-74788

    NEUROCRINE BIOSCIENCES INC

    CAH - Congenital Adrenal Hyperplasia

    phase 2 small molecule completed

    1 trial
  12. NBI-74788

    NEUROCRINE BIOSCIENCES INC

    Congenital adrenal hyperplasia (CAH)

    phase 2 small molecule active

    1 trial
  13. NBI-827104

    NEUROCRINE BIOSCIENCES INC

    Essential Tremor

    phase 2 small molecule completed

    1 trial
  14. NBI-827104

    NEUROCRINE BIOSCIENCES INC

    Epileptic Encephalopathy

    phase 2 small molecule terminated

    2 trials
  15. NBI-921352

    NEUROCRINE BIOSCIENCES INC

    Focal Onset Seizure

    phase 2 small molecule completed

    2 trials
  16. NBI-921352

    NEUROCRINE BIOSCIENCES INC

    SCN8A Developmental and Epileptic Encephalopathy Syndrome

    phase 2 small molecule active

    2 trials
  17. NBI-98854

    NEUROCRINE BIOSCIENCES INC

    Tourette Syndrome

    phase 2 small molecule terminated

    4 trials
  18. Placebo

    NEUROCRINE BIOSCIENCES INC

    Major Depressive Disorder

    phase 2 small molecule completed

    1 trial
  19. Placebo

    NEUROCRINE BIOSCIENCES INC

    Anhedonia

    phase 2 small molecule completed

    1 trial
  20. TAK-041

    NEUROCRINE BIOSCIENCES INC

    Stable Schizophrenia

    phase 2 small molecule completed

    1 trial
  21. TAK-831

    NEUROCRINE BIOSCIENCES INC

    Friedreich Ataxia

    phase 2 small molecule completed

    1 trial
  22. Valbenazine

    NEUROCRINE BIOSCIENCES INC

    Obsessive-Compulsive Disorder

    phase 2 small molecule active

    1 trial
  23. Valbenazine

    NEUROCRINE BIOSCIENCES INC

    Tourette Syndrome

    phase 2 small molecule completed

    4 trials
  24. Valbenazine Oral Capsule

    NEUROCRINE BIOSCIENCES INC

    Trichotillomania (Hair-Pulling Disorder)

    phase 2 small molecule active

    1 trial
  25. interleukin-4 PE38KDEL cytotoxin

    NEUROCRINE BIOSCIENCES INC

    Brain and Central Nervous System Tumors

    phase 2 mab completed

    1 trial

Frequently asked questions

How many pipeline programs does NEUROCRINE BIOSCIENCES have?

25 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs